Actionable Benefits
- Strategic planning for pharmaceutical vendors and distributors for changes in serialization regulations.
- Gain insight into scale and scope of regulations.
- Guidance into proposed future regulatory changes.
Research Highlights
- Regional focus on North America (US and Canada).
- Identifies variation between North American regulations and other regions.
- Comparison and analysis of different levels of traceability.
Critical Questions Answered
- What is the timeline for implementation of serialization regulations?
- What are the key data standards and mandates for traceability?
- How are international standards like GS1 leveraged in national regulations?
Who Should Read This?
- Strategy planners and advisors within the pharmaceutical and supporting logistics industry.
- Managers aiming to identify regulatory requirements of their operations.
- For serialization software and hardware providers to assess regulatory impact on the pharmaceutical market.
Related Research
Asset Visibility: Pharma Industry Track and Trace Regulations in Asia-Pacific
Presentation | 2Q 2022 | PT-2577
Asset Visibility: Pharma Industry Track and Trace Regulations in the Rest of the World
Presentation | 2Q 2022 | PT-2571
Asset Visibility: Pharma Industry Track and Trace Regulations in Europe
Presentation | 1Q 2022 | PT-2570